Factors associated with emotional distress in newly-diagnosed prostate cancer identified
the ONA take:
According to a new study published in the journal Psycho-Oncology, researchers from the University at Buffalo Department of Community Health and Health Behavior in Buffalo, New York, have identified certain factors associated with emotional distress in men with newly diagnosed prostate cancer.
For the study, researchers sought to identify factors associated with significant emotional distress in men with newly diagnosed prostate cancer so that may identify acceptable intervention strategies to manage that distress.
Researchers identified 1,425 men with newly diagnosed clinically localized prostate cancer who had not received treatment for their disease yet.
Participants used the Distress Thermometer to report how much distress they were experiencing and identify what problems they experienced in the past week. Results showed that low self-efficacy for decision-making, low confidence in cancer control, masculine identity threat, low optimism, and low resilience were associated with higher emotional distress.
The findings suggest that improving communication about prostate cancer prognosis, providing decision-making support, and referring to brief cognitive behavioral interventions may be useful approaches at mitigating significant emotional distress for those with newly diagnosed prostate cancer.
Researchers identified certain factors associated with emotional distress in men with newly diagnosed prostate cancer.
- Physical Activity Improves Outcomes for Patients with Breast Cancer and Survivors
- Behavior Pain Assessment Tool Measures Pain In Patients Who Cannot Communicate Verbally
- Whole Genome Sequencing Reveals that 12% of Childhood Cancer Survivors Have Mutations in Genes that Increase Cancer Risk
- Increased 5-Year Survival Rate Seen in NSCLC Subset Treated With Nivolumab
- Novel Test For Multiple Myeloma Uses Microchip, Conventional Blood Sample
- Exercise, Psychological Interventions Better for Cancer Fatigue Than Medications
- ASCO Issues Global Guidance for HPV Vaccination for Cervical Cancer Prevention
- Discharge Events Improved With Standardized Inpatient Palliative Care Consultation
- Little Opposition to Early Palliative Care for Symptom Management in Pediatric Oncology
- Updated ASTRO Guideline Bolsters Safety, Efficacy of Palliative RT for Bone Metastases
- Thyroid Cancer Incidence Increasing Among Younger, Hispanic, African American Populations
- JAK1, JAK2 Inhibition Improves Outcomes in Myeloproliferative Neoplasms, But More Is Needed
- Recommendations Against Contralateral Prophylactic Mastectomy Not Tied to Patient Satisfaction
- Self-efficacy Level Predictive of Likelihood to Follow Through With Colorectal Cancer Screening
- Chronic Myeloproliferative Neoplasms Treatment (Fact Sheet)
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|